Senate To Make Another Run At Drug Cost Control
2/3/22 12:29 PM
A bill targeting drug costs that the Senate plans to take up next week would cap the cost of insulin at $25 a month for consumers, one of a series of measures that a senator behind the legislation said are aimed at boosting access and accountability in the pharmaceutical system.
Get the rest of the story!
Click here to start your free, no‑obligation, 21-day trial.